Valuation: Grifols, S.A.

Capitalization 6.39B 7.36B 6.01B 5.46B 10.07B 636B 11.29B 70.6B 27.29B 291B 27.62B 27.03B 1,064B P/E ratio 2025 *
16.5x
P/E ratio 2026 * 11.4x
Enterprise value 15.43B 17.78B 14.52B 13.19B 24.32B 1,536B 27.26B 171B 65.89B 703B 66.7B 65.28B 2,570B EV / Sales 2025 *
2.02x
EV / Sales 2026 * 1.83x
Free-Float
79.4%
Yield 2025 *
-
Yield 2026 * 1.86%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.24%
1 week-1.33%
Current month+9.56%
1 month+15.28%
3 months+9.14%
6 months+6.19%
Current year+13.41%
More quotes
1 week 10.08
Extreme 10.08
10.74
1 month 8.95
Extreme 8.95
10.74
Current year 7.32
Extreme 7.324
11.27
1 year 7.32
Extreme 7.324
11.35
3 years 6.36
Extreme 6.362
19.58
5 years 6.36
Extreme 6.362
28.84
10 years 6.36
Extreme 6.362
34.31
More quotes
Manager TitleAgeSince
Chief Executive Officer 56 31/03/2024
Chief Tech/Sci/R&D Officer 51 31/08/2023
Corporate Officer/Principal 69 30/04/2016
Director TitleAgeSince
Director/Board Member 69 12/04/2000
Director/Board Member 62 23/05/2015
Director/Board Member 49 29/05/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.24%-1.33%+13.44%-42.04% 7.44B
+1.12%-0.88%-16.22%-5.48% 75.35B
-0.59%+0.40%+36.41%+20.67% 52.44B
-1.90%-5.86%+13.08%+97.64% 34.64B
+0.01%-4.90%-43.42%-37.28% 18.54B
+1.95%-3.08%+106.57%+192.19% 16.22B
-0.63%+0.51%+47.66%+735.98% 15.5B
-0.04%-.--%+74.71%+140.03% 14.02B
-0.83%-0.84%+11.12%-4.21% 13.32B
-1.93%-6.90%-5.74%-41.10% 11.29B
Average -0.41%-2.33%+23.76%+105.64% 25.88B
Weighted average by Cap. -0.13%-2.46%+15.59%+73.49%
See all sector performances

Financials

2025 *2026 *
Net sales 7.65B 8.81B 7.2B 6.54B 12.06B 762B 13.52B 84.55B 32.68B 348B 33.07B 32.37B 1,275B 8.2B 9.45B 7.72B 7.01B 12.92B 816B 14.48B 90.61B 35.02B 373B 35.44B 34.69B 1,366B
Net income 417M 480M 392M 356M 657M 41.51B 736M 4.61B 1.78B 18.99B 1.8B 1.76B 69.45B 605M 697M 569M 517M 954M 60.22B 1.07B 6.68B 2.58B 27.55B 2.61B 2.56B 101B
Net Debt 9.04B 10.41B 8.51B 7.73B 14.25B 900B 15.97B 99.9B 38.61B 412B 39.08B 38.25B 1,506B 8.58B 9.89B 8.08B 7.34B 13.53B 854B 15.16B 94.83B 36.65B 391B 37.09B 36.31B 1,429B
More financial data * Estimated data
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (85.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (3%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (2.9%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.9%), European Union (15.5%), the United States and Canada (56.7%) and other (21.9%).
Employees
23,800
More about the company
Date Price Change Volume
18/06/25 10.38 -1.24% 2,173,572
17/06/25 10.50 -1.18% 1,672,322
16/06/25 10.63 +4.27% 2,625,849
13/06/25 10.20 -3.23% 2,715,257
12/06/25 10.54 +0.67% 1,707,379

Delayed Quote BME, June 18, 2025 at 04:35 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
10.38EUR
Average target price
15.96EUR
Spread / Average Target
+53.85%
Consensus

Quarterly revenue - Rate of surprise